Cargando…
MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson’s disease
Parkinson’s disease is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra with no effective cure available. MicroRNA-124 has been regarded as a promising therapeutic entity for Parkinson’s disease due to its pro-neurogenic and neuroprotective roles....
Autores principales: | Esteves, Marta, Abreu, Ricardo, Fernandes, Hugo, Serra-Almeida, Catarina, Martins, Patrícia A.T., Barão, Marta, Cristóvão, Ana Clara, Saraiva, Cláudia, Ferreira, Raquel, Ferreira, Lino, Bernardino, Liliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552816/ https://www.ncbi.nlm.nih.gov/pubmed/35689381 http://dx.doi.org/10.1016/j.ymthe.2022.06.003 |
Ejemplares similares
-
C-Terminal Binding Proteins Promote Neurogenesis and Oligodendrogenesis in the Subventricular Zone
por: Serra-Almeida, Catarina, et al.
Publicado: (2021) -
Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease
por: Esteves, Marta, et al.
Publicado: (2015) -
CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival
por: Saraiva, Cláudia, et al.
Publicado: (2023) -
MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo
por: Saraiva, Cláudia, et al.
Publicado: (2018) -
Histamine modulates hippocampal inflammation and neurogenesis in adult mice
por: Saraiva, Cláudia, et al.
Publicado: (2019)